Found: 104
Select item for more details and to access through your institution.
Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses.
- Published in:
- JNCI Cancer Spectrum, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1093/jncics/pkz002
- By:
- Publication type:
- Article
Erratum: Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2+ Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice
The ARCAD Clinical Trials Program: An Update and Invitation.
- Published in:
- Oncologist, 2012, v. 17, n. 2, p. 188, doi. 10.1634/theoncologist.2011-0332
- By:
- Publication type:
- Article
Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2 Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy.
- Published in:
- Oncologist, 2012, v. 17, n. 1, p. 26, doi. 10.1634/theoncologist.2011-0212
- By:
- Publication type:
- Article
Validation of surrogate end points in multiple randomized clinical trials with failure time end points.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2001, v. 50, n. 4, p. 405, doi. 10.1111/1467-9876.00244
- By:
- Publication type:
- Article
Trial Design for Cancer Immunotherapy: A Methodological Toolkit.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4669, doi. 10.3390/cancers15184669
- By:
- Publication type:
- Article
Statistical Considerations for Trials in Adjuvant Treatment of Colorectal Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3442, doi. 10.3390/cancers12113442
- By:
- Publication type:
- Article
Minimization in randomized clinical trials.
- Published in:
- Statistics in Medicine, 2023, v. 42, n. 28, p. 5285, doi. 10.1002/sim.9916
- By:
- Publication type:
- Article
Individualized Net Benefit estimation and meta‐analysis using generalized pairwise comparisons in N‐of‐1 trials.
- Published in:
- Statistics in Medicine, 2023, v. 42, n. 6, p. 878, doi. 10.1002/sim.9648
- By:
- Publication type:
- Article
Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: A simulation study.
- Published in:
- Statistics in Medicine, 2021, v. 40, n. 3, p. 553, doi. 10.1002/sim.8788
- By:
- Publication type:
- Article
Exploring and validating surrogate endpoints in colorectal cancer.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Surrogacy Beyond Prognosis: The Importance of "Trial-Level" Surrogacy.
- Published in:
- Oncologist, 2022, v. 27, n. 4, p. 266, doi. 10.1093/oncolo/oyac006
- By:
- Publication type:
- Article
Adjuvant reactivity predicts survival in patients with 'high-risk' primary malignant melanoma treated with systemic BCG.
- Published in:
- International Journal of Cancer, 1981, v. 28, n. 5, p. 543, doi. 10.1002/ijc.2910280503
- By:
- Publication type:
- Article
Common pitfalls in statistical analysis: The perils of multiple testing.
- Published in:
- Perspectives in Clinical Research, 2016, v. 7, n. 2, p. 106, doi. 10.4103/2229-3485.179436
- By:
- Publication type:
- Article
Common pitfalls in statistical analysis: Clinical versus statistical significance.
- Published in:
- Perspectives in Clinical Research, 2015, v. 6, n. 3, p. 169, doi. 10.4103/2229-3485.159943
- By:
- Publication type:
- Article
Common pitfalls in statistical analysis: "P" values, statistical significance and confidence intervals.
- Published in:
- Perspectives in Clinical Research, 2015, v. 6, n. 2, p. 116, doi. 10.4103/2229-3485.154016
- By:
- Publication type:
- Article
Common pitfalls in statistical analysis: "No evidence of effect" versus "evidence of no effect".
- Published in:
- Perspectives in Clinical Research, 2015, v. 6, n. 1, p. 62, doi. 10.4103/2229-3485.148821
- By:
- Publication type:
- Article
Relationship Between Carfilzomib Dose and Efficacy Outcomes in Patients With Relapsed and/or Refractory Multiple Myeloma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
EMA Guidance Points to Central Statistical Monitoring.
- Published in:
- Applied Clinical Trials, 2014, v. 23, n. 2/3, p. 34
- By:
- Publication type:
- Article
On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomes.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 2, p. 284, doi. 10.1002/pst.2271
- By:
- Publication type:
- Article
Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long‐term clinical endpoint.
- Published in:
- Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 209, doi. 10.1002/pst.2165
- By:
- Publication type:
- Article
Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validation.
- Published in:
- Pharmaceutical Statistics, 2006, v. 5, n. 3, p. 173, doi. 10.1002/pst.207
- By:
- Publication type:
- Article
Statistical validation of surrogate outcome measures.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Assessment of the consistency and robustness of results from a multicenter trial of remission maintenance therapy for acute myeloid leukemia.
- Published in:
- Trials, 2011, v. 12, n. 1, p. 86, doi. 10.1186/1745-6215-12-86
- By:
- Publication type:
- Article
Generalized pairwise comparisons of prioritized outcomes are a powerful and patient-centric analysis of multi-domain scores.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13023-023-02943-8
- By:
- Publication type:
- Article
A perspective on surrogate endpoints in controlled clinical trials.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Validation of Surrogate Endpoints in Multiple Randomized Clinical Trials with Discrete Outcomes.
- Published in:
- Biometrical Journal, 2002, v. 44, n. 8, p. 921, doi. 10.1002/bimj.200290004
- By:
- Publication type:
- Article
Improving public health by improving clinical trial guidelines and their application.
- Published in:
- European Heart Journal, 2017, v. 38, n. 21, p. 1632, doi. 10.1093/eurheartj/ehx086
- By:
- Publication type:
- Article
Assessment of Statistical Heterogeneity in the PLATO Trial.
- Published in:
- Cardiology, 2011, v. 118, n. 2, p. 138, doi. 10.1159/000327592
- By:
- Publication type:
- Article
Generalized pairwise comparisons for censored data: An overview.
- Published in:
- Biometrical Journal, 2023, v. 65, n. 2, p. 1, doi. 10.1002/bimj.202100354
- By:
- Publication type:
- Article
Correcting the bias of the net benefit estimator due to right‐censored observations.
- Published in:
- Biometrical Journal, 2021, v. 63, n. 4, p. 893, doi. 10.1002/bimj.202000001
- By:
- Publication type:
- Article
A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisons.
- Published in:
- Biometrical Journal, 2021, v. 63, n. 2, p. 272, doi. 10.1002/bimj.201900354
- By:
- Publication type:
- Article
Statistical evaluation of surrogate endpoints with examples from cancer clinical trials.
- Published in:
- Biometrical Journal, 2016, v. 58, n. 1, p. 104, doi. 10.1002/bimj.201400049
- By:
- Publication type:
- Article
Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 21, p. 1600, doi. 10.1093/jnci/djt270
- By:
- Publication type:
- Article
Adjuvant Chemotherapy With Sequential or Concurrent Anthracycline and Docetaxel: Breast International Group 02-98 Randomized Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 2, p. 121, doi. 10.1 093/i nci/djm287
- By:
- Publication type:
- Article
Endpoints in Adjuvant Treatment Trials: A Systematic Review of the Literature in Colon Cancer and Proposed Definitions for Future Trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 13, p. 998, doi. 10.1093/jnci/djm024
- By:
- Publication type:
- Article
Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 17, p. 1183, doi. 10.1093/jnci/djj329
- By:
- Publication type:
- Article
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 4, p. 262, doi. 10.1093/jnci/djj052
- By:
- Publication type:
- Article
VALIDATION OF SURROGATE ENDPOINTS IN ADVANCED SOLID TUMORS: SYSTEMATIC REVIEW OF STATISTICAL METHODS, RESULTS, AND IMPLICATIONS FOR POLICY MAKERS.
- Published in:
- International Journal of Technology Assessment in Health Care, 2014, v. 30, n. 3, p. 312, doi. 10.1017/S0266462314000300
- By:
- Publication type:
- Article
Authors' Reply to Schoenfeld: 'Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors'.
- Published in:
- Drugs, 2017, v. 77, n. 10, p. 1139, doi. 10.1007/s40265-017-0761-x
- By:
- Publication type:
- Article
Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial.
- Published in:
- 2012
- By:
- Publication type:
- journal article
An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference.
- Published in:
- Biometrics, 2016, v. 72, n. 3, p. 669, doi. 10.1111/biom.12483
- By:
- Publication type:
- Article
On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpoints.
- Published in:
- Biometrics, 2015, v. 71, n. 1, p. 15, doi. 10.1111/biom.12245
- By:
- Publication type:
- Article
Predicting Treatment Effect from Surrogate Endpoints and Historical Trials: An Extrapolation Involving Probabilities of a Binary Outcome or Survival to a Specific Time.
- Published in:
- Biometrics, 2012, v. 68, n. 1, p. 248, doi. 10.1111/j.1541-0420.2011.01646.x
- By:
- Publication type:
- Article
Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints.
- Published in:
- Biometrics, 2004, v. 60, n. 3, p. 724, doi. 10.1111/j.0006-341X.2004.00222.x
- By:
- Publication type:
- Article
Introducing new treatment for cancer: Practical, Ethical and legal Problems, C. J. Williams (ed), Wiley, Chichester, 1992. No. of pages: xiv + 492. Price: £24.95 (paper), 0-471-93113-6 (Cloth).
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 7, p. 713, doi. 10.1002/sim.4780120710
- By:
- Publication type:
- Article
Interim analyses, stopping rules and data monitoring in clinical trials in europe.
- Published in:
- Statistics in Medicine, 1993, v. 12, n. 5/6, p. 509, doi. 10.1002/sim.4780120517
- By:
- Publication type:
- Article
Issues of efficiency in combining proportions of deaths from several clinical trials.
- Published in:
- Statistics in Medicine, 1987, v. 6, n. 5, p. 565, doi. 10.1002/sim.4780060505
- By:
- Publication type:
- Article
Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 152, n. 2, p. 399, doi. 10.1007/s10549-015-3466-4
- By:
- Publication type:
- Article
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005).
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 138, n. 1, p. 99, doi. 10.1007/s10549-013-2444-y
- By:
- Publication type:
- Article